Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 200533
Company: COLLEGIUM PHARM INC
Company: COLLEGIUM PHARM INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 200MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 250MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/25/2011 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200533s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/200533s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/200533Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/14/2024 | SUPPL-29 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200533s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/200533Orig1s029ltr.pdf | |
12/15/2023 | SUPPL-27 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/200533Orig1s027ltr.pdf | |
03/04/2021 | SUPPL-23 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200533s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/200533Orig1s023ltr.pdf | |
10/07/2019 | SUPPL-20 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200533s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/200533Orig1s020ltr.pdf | |
09/18/2018 | SUPPL-19 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200533s018s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/200533Orig1s018s019ltr.pdf | |
09/18/2018 | SUPPL-18 | REMS - MODIFIED - D-N-A |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200533s018s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/200533Orig1s018s019ltr.pdf | |
05/26/2017 | SUPPL-16 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/200533Orig1s016ltr.pdf |
09/30/2016 | SUPPL-15 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/200533Orig1s015ltr.pdf |
12/16/2016 | SUPPL-14 | Labeling-Package Insert, Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/200533s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/200533Orig1s014ltr.pdf | |
04/20/2016 | SUPPL-13 | REMS-Modified |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/200533Orig1s013ltr.pdf |
06/26/2015 | SUPPL-12 | REMS-Modified |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/200533Orig1s012ltr.pdf |
08/19/2014 | SUPPL-11 | REMS-Modified |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/200533Orig1s011ltr.pdf |
04/16/2014 | SUPPL-10 | Labeling-Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/200533s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/200533Orig1s010ltr.pdf | |
01/16/2014 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/15/2013 | SUPPL-4 | REMS-Modified |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/200533Orig1s004ltr.pdf |
07/09/2012 | SUPPL-2 | REMS-Modified |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200533s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/200533Orig1s002ltr.pdf | |
08/28/2012 | SUPPL-1 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200533s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/200533Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/14/2024 | SUPPL-29 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200533s029lbl.pdf | |
12/15/2023 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf | |
12/15/2023 | SUPPL-27 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf | |
03/04/2021 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200533s023lbl.pdf | |
10/07/2019 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200533s020lbl.pdf | |
09/18/2018 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200533s018s019lbl.pdf | |
09/18/2018 | SUPPL-18 | REMS - MODIFIED - D-N-A | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200533s018s019lbl.pdf | |
12/16/2016 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/200533s014lbl.pdf | |
12/16/2016 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/200533s014lbl.pdf | |
12/16/2016 | SUPPL-14 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/200533s014lbl.pdf | |
04/16/2014 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/200533s010lbl.pdf | |
04/16/2014 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/200533s010lbl.pdf | |
08/28/2012 | SUPPL-1 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200533s001lbl.pdf | |
07/09/2012 | SUPPL-2 | REMS-Modified | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200533s002lbl.pdf | |
08/25/2011 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200533s000lbl.pdf |